Reuters logo
BRIEF-Almirall announces phase III positive Duaklir results for COPD
September 7, 2017 / 7:54 AM / 2 months ago

BRIEF-Almirall announces phase III positive Duaklir results for COPD

Sept 7 (Reuters) - ALMIRALL SA:

* SAYS PHASE III STUDY SHOWS DUAKLIR SIGNIFICANTLY IMPROVES LUNG FUNCTION IN MODERATE TO VERY SEVERE STABLE COPD

* TO GET SALES-RELATED MILESTONES FROM ASTRAZENECA ASSOCIATED TO DUAKLIR SALES IN US, ACCORDING TO GLOBAL COLLABORATION BETWEEN BOTH COMPANIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below